
Christopher Upton
Examiner (ID: 12246, Phone: (571)272-1169 , Office: P/1778 )
| Most Active Art Unit | 1778 |
| Art Unit(s) | 1776, 1308, 1778, 1724, 1306, 1797 |
| Total Applications | 3146 |
| Issued Applications | 2580 |
| Pending Applications | 123 |
| Abandoned Applications | 451 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13987297
[patent_doc_number] => 20190062806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => NUCLEIC ACID PRESERVATION SOLUTION AND METHODS OF MANUFACTURE AND USE
[patent_app_type] => utility
[patent_app_number] => 16/176210
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16176210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/176210 | Nucleic acid preservation solution and methods of manufacture and use | Oct 30, 2018 | Issued |
Array
(
[id] => 13958499
[patent_doc_number] => 20190055593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/175353
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16175353
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/175353 | SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS | Oct 29, 2018 | Abandoned |
Array
(
[id] => 13929781
[patent_doc_number] => 20190048406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => Oxidising Agent for Modified Nucleotides
[patent_app_type] => utility
[patent_app_number] => 16/171744
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16171744
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/171744 | Oxidising Agent for Modified Nucleotides | Oct 25, 2018 | Abandoned |
Array
(
[id] => 13929783
[patent_doc_number] => 20190048407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/172369
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16172369
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/172369 | SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS | Oct 25, 2018 | Abandoned |
Array
(
[id] => 16344002
[patent_doc_number] => 20200308652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => DIAGNOSIS AND/OR PROGNOSIS OF HER2-DEPENDENT CANCER USING MOESIN AS A BIOMARKER
[patent_app_type] => utility
[patent_app_number] => 16/758644
[patent_app_country] => US
[patent_app_date] => 2018-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758644
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/758644 | DIAGNOSIS AND/OR PROGNOSIS OF HER2-DEPENDENT CANCER USING MOESIN AS A BIOMARKER | Oct 23, 2018 | Abandoned |
Array
(
[id] => 16606203
[patent_doc_number] => 10907198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Assay systems for genetic analysis
[patent_app_type] => utility
[patent_app_number] => 16/159588
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 11
[patent_no_of_words] => 35071
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 450
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16159588
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/159588 | Assay systems for genetic analysis | Oct 11, 2018 | Issued |
Array
(
[id] => 14214735
[patent_doc_number] => 20190119752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => ASSAY SYSTEMS FOR GENETIC ANALYSIS
[patent_app_type] => utility
[patent_app_number] => 16/159575
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16159575
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/159575 | Assay systems for genetic analysis | Oct 11, 2018 | Issued |
Array
(
[id] => 14073055
[patent_doc_number] => 20190085415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => Microarray Based Multiplex Pathogen Analysis and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/158276
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27006
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 416
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16158276
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/158276 | Microarray based multiplex pathogen analysis and uses thereof | Oct 10, 2018 | Issued |
Array
(
[id] => 14073053
[patent_doc_number] => 20190085414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => Microarray Based Multiplex Pathogen Analysis and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/158181
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16158181
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/158181 | Microarray based multiplex pathogen analysis and uses thereof | Oct 10, 2018 | Issued |
Array
(
[id] => 14102943
[patent_doc_number] => 20190093147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => PURIFICATION PROCESS OF NASCENT DNA
[patent_app_type] => utility
[patent_app_number] => 16/155421
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16155421
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/155421 | PURIFICATION PROCESS OF NASCENT DNA | Oct 8, 2018 | Abandoned |
Array
(
[id] => 14073021
[patent_doc_number] => 20190085398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => Compositions and Methods for Diagnosing Diseases and Disorders Associated with Beta Cell Death
[patent_app_type] => utility
[patent_app_number] => 16/140592
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16140592
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/140592 | Compositions and Methods for Diagnosing Diseases and Disorders Associated with Beta Cell Death | Sep 24, 2018 | Abandoned |
Array
(
[id] => 13829101
[patent_doc_number] => 20190018035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => HIV VIRAL LOAD TESTING
[patent_app_type] => utility
[patent_app_number] => 16/133784
[patent_app_country] => US
[patent_app_date] => 2018-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133784
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/133784 | HIV VIRAL LOAD TESTING | Sep 17, 2018 | Pending |
Array
(
[id] => 17905756
[patent_doc_number] => 11459602
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Method for generating double stranded DNA libraries and sequencing methods for the identification of methylated cytosines
[patent_app_type] => utility
[patent_app_number] => 16/133842
[patent_app_country] => US
[patent_app_date] => 2018-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 42521
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/133842 | Method for generating double stranded DNA libraries and sequencing methods for the identification of methylated cytosines | Sep 17, 2018 | Issued |
Array
(
[id] => 16298131
[patent_doc_number] => 20200283854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => METHOD FOR METHYLATION ANALYSIS
[patent_app_type] => utility
[patent_app_number] => 16/645749
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645749
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645749 | METHOD FOR METHYLATION ANALYSIS | Sep 13, 2018 | Abandoned |
Array
(
[id] => 13794039
[patent_doc_number] => 20190010558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => METHOD FOR DETERMINING THE RISK OF RECURRENCE OF AN ESTROGEN RECEPTOR-POSITIVE AND HER2-NEGATIVE PRIMARY MAMMARY CARCINOMA UNDER AN ENDOCRINE THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/124915
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16124915
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/124915 | METHOD FOR DETERMINING THE RISK OF RECURRENCE OF AN ESTROGEN RECEPTOR-POSITIVE AND HER2-NEGATIVE PRIMARY MAMMARY CARCINOMA UNDER AN ENDOCRINE THERAPY | Sep 6, 2018 | Abandoned |
Array
(
[id] => 16422257
[patent_doc_number] => 20200347455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => Clear Cell Renal Cell Carcinoma Biomarkers
[patent_app_type] => utility
[patent_app_number] => 16/642430
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642430
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642430 | Clear Cell Renal Cell Carcinoma Biomarkers | Sep 4, 2018 | Abandoned |
Array
(
[id] => 16901212
[patent_doc_number] => 20210180128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => METHOD TO CONFIRM VARIANTS IN NGS PANEL TESTING BY SNP GENOTYPING
[patent_app_type] => utility
[patent_app_number] => 16/643197
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643197
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/643197 | METHOD TO CONFIRM VARIANTS IN NGS PANEL TESTING BY SNP GENOTYPING | Aug 27, 2018 | Abandoned |
Array
(
[id] => 14439855
[patent_doc_number] => 20190177800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => METHODS AND COMPOSITIONS FOR LABELING CELLS
[patent_app_type] => utility
[patent_app_number] => 16/107685
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16107685
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/107685 | METHODS AND COMPOSITIONS FOR LABELING CELLS | Aug 20, 2018 | Abandoned |
Array
(
[id] => 14185923
[patent_doc_number] => 20190112666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => Methods for evaluating tumor cell spheroids using 3d microfluidic cell culture device
[patent_app_type] => utility
[patent_app_number] => 15/999230
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34248
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999230
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/999230 | Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture device | Aug 16, 2018 | Issued |
Array
(
[id] => 13590847
[patent_doc_number] => 20180346972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => STABLE NANOREPORTERS
[patent_app_type] => utility
[patent_app_number] => 16/103369
[patent_app_country] => US
[patent_app_date] => 2018-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16103369
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/103369 | STABLE NANOREPORTERS | Aug 13, 2018 | Abandoned |